SCHEMBL433535

SCHEMBL433535

CC(C)CCCCC(=O)OCCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.47
MGLL Q99685 1/20 0.45
MAPT P10636 1/20 0.41
DNM1 Q05193 1/20 0.40
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 1/20 0.39
DUSP3 P51452 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.39
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4C Q9H3R0 2/20 0.38
KDM4A O75164 1/20 0.38
PHF8 Q9UPP1 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
RARB P10826 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11664799 0.98 DGKA (0.50) DGKAMGLLMAPTDNM1KDM4E
SCHEMBL3065242 0.98 DGKA (0.50) DGKAMGLLMAPTDNM1KDM4E
SCHEMBL28259218 0.98 DGKA (0.46) DGKAMGLLMAPTDNM1CYP3A4
SCHEMBL2531968 0.94 MGLL (0.46) DGKAMGLLMAPTDNM1CYP3A4
SCHEMBL9541849 0.92 DGKA (0.62) DGKAMGLLMAPTDNM1KDM4E
Propionic Acid SCHEMBL27714866 0.90 DGKA (0.47) DGKAMGLLMAPTDNM1KDM4E
SCHEMBL1011923 0.90 DGKA (0.57) DGKAMAPTDNM1CYP3A4TSHR
SCHEMBL28606802 0.90 EPHX2 (0.47) DGKAMGLLMAPTDNM1CYP3A4
SCHEMBL28377219 0.90 EPHX2 (0.47) DGKAMGLLMAPTDNM1CYP3A4
SCHEMBL31402368 0.89 DGKA (0.48) DGKAMAPTDNM1KDM4EDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109390711-B Cold sealing terminal of anaerobic sealant 苏州晗普新材料科技有限公司 2024-05-14 CN claimed
CN-113144679-B Metallographic cold-inlaid high-transparency epoxy resin defoaming agent and application thereof 烟台大学 2022-04-26 CN claimed
CN-113144679-A Metallographic cold-inlaid high-transparency epoxy resin defoaming agent and application thereof 烟台大学 2021-07-23 CN claimed
CN-109390711-B Cold sealing terminal of anaerobic sealant 苏州晗普新材料科技有限公司 2024-05-14 CN disclosed
CN-113144679-B Metallographic cold-inlaid high-transparency epoxy resin defoaming agent and application thereof 烟台大学 2022-04-26 CN disclosed
CN-108245435-B Spray-type foam oxidation hair dye composition 朋友株式会社 2021-07-27 CN disclosed
CN-113144679-A Metallographic cold-inlaid high-transparency epoxy resin defoaming agent and application thereof 烟台大学 2021-07-23 CN disclosed
EP-1522316-B1 TRANSDERMAL ABSORPTION PREPARATION HISAMITSU PHARMACEUTICAL CO (JP) 2018-02-21 EP disclosed
EP-2351566-B1 PHARMACEUTICAL COMPOSITION IMPROVED IN ABSORPTION THROUGH INTESTINAL TRACT SANTEN PHARMACEUTICAL CO LTD (JP) 2014-12-10 EP disclosed
WO-2012010685-A2 DOUBLE SALT-CONTAINING ALCOHOLIC ANTIPERSPIRANTS HENKEL AG & CO. KGAA (DE) 2012-01-26 WO disclosed
US-20110201655-A1 PHARMACEUTICAL COMPOSITION IMPROVING INTESTINAL ABSORPTION SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-08-18 US disclosed
EP-1174132-A1 PERCUTANEOUS ABSORPTION PREPARATIONS CONTAINING OXYBUTYNIN Lead Chemical Co. Ltd. (JP) 2002-01-23 EP disclosed
US-6337360-B1 APPLYING METHACRYLATE POLYMER TO METAL SURFACE AFTER POLYMERIZATION ROEHM GMBH CHEMISCHE FABRIK (DE) 2002-01-08 US disclosed
US-6316473-B1 GOOD DRUG RELEASE AND ABSORPTION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6248350-B1 ANTIINFLAMMATORY ANALGESIC PATCH LEAD CHEMICAL CO., LTD. (JP) 2001-06-19 US disclosed
US-6201009-B1 MIXTURE OF PANTOTHENIC ACID DERIVATIVE, NEUTRALIZED OR ESTERIFIED ACID, AND A NONIONIC SURFACTANT; BIOAVAILABILITY FUJIREBIO INC. (JP) 2001-03-13 US disclosed
EP-0998927-A1 Absorption-enhancing composition for pantothenic acid derivative FUJIREBIO INC. (JP) 2000-05-10 EP disclosed
EP-0978288-A1 MEDICINAL COMPOSITION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-02-09 EP disclosed
EP-0947584-A1 LOXOPROFEN-CONTAINING PREPARATION FOR EXTERNAL USE LEAD CHEMICAL COMPANY LTD. (JP) 1999-10-06 EP disclosed
EP-0943327-A1 MEDICINAL COMPOSITION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-09-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201655-A1 PHARMACEUTICAL COMPOSITION IMPROVING INTESTINAL ABSORPTION SLC10A2, NR1H4, SLC10A6 DGKA 3424/4885MGLL 1011/4885MAPT 4574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.